143 related articles for article (PubMed ID: 8051625)
1. Nondetection of HTLV-I/II and HIV-2 in Thailand, 1991-1992.
Lohsomboon P; Young NL; Weniger BG; Atikij B; Limpakarnjanarat K; Khabbaz RF; Kaplan JE
J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):992-4. PubMed ID: 8051625
[No Abstract] [Full Text] [Related]
2. Human retroviruses in Amerindians of Colombia: high prevalence of human T cell lymphotropic virus type II infection among the Tunebo Indians.
Duenas-Barajas E; Bernal JE; Vaught DR; Nerurkar VR; Sarmiento P; Yanagihara R; Gajdusek DC
Am J Trop Med Hyg; 1993 Dec; 49(6):657-63. PubMed ID: 8279632
[TBL] [Abstract][Full Text] [Related]
3. Infection with human immunodeficiency viruses and human T-cell lymphotropic viruses in the same individuals in Nigeria.
Olaleye OD; Ekweozor CC
Rev Roum Virol; 1993; 44(3-4):233-6. PubMed ID: 7826875
[TBL] [Abstract][Full Text] [Related]
4. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
[TBL] [Abstract][Full Text] [Related]
5. Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil.
Andrade TM; Dourado I; Galvão-Castro B
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):186-7. PubMed ID: 9637584
[No Abstract] [Full Text] [Related]
6. HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.
Pinheiro SR; Carneiro-Proietti AB; Lima-Martins MV; Proietti FA; Pereira AA; Oréfice F
Rev Soc Bras Med Trop; 1996; 29(4):383-4. PubMed ID: 8768591
[No Abstract] [Full Text] [Related]
7. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China.
Cao F; Ji Y; Huang R; Lin S
Vox Sang; 1998; 75(2):154. PubMed ID: 9784671
[No Abstract] [Full Text] [Related]
8. Absence of HTLV-I infection in patients with malignancy in the Yucatan peninsula.
Góngora-Biachi RA; González-Martínez P; Puerto FI; Bastarrachea-Ortíz J; Yamaguchi K; Nishimura Y; Takatsuki K
Rev Invest Clin; 1993; 45(3):281-2. PubMed ID: 8210771
[No Abstract] [Full Text] [Related]
9. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
[TBL] [Abstract][Full Text] [Related]
10. [Retrovirus: diagnostic tests and their interpretation (II). HIV-2, HTLV-I, and HTLV-II infection].
Soriano V; Gutiérrez M; González-Lahoz J
Med Clin (Barc); 1993 Sep; 101(7):264-8. PubMed ID: 7746003
[No Abstract] [Full Text] [Related]
11. HTLV-I/II antibodies among three different Indian groups from Paraguay.
de Cabral MB; Vera ME; Samudio M; Arias AR; Cabello A; Moreno R; Zapiola I; Bouzas MB; Muchinik G
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):548-9. PubMed ID: 9859972
[No Abstract] [Full Text] [Related]
12. [Retrovirus and blood transfusion].
Barrera JM; Ercilla MG; Gil BC
Sangre (Barc); 1993 Jun; 38(3):187-92. PubMed ID: 8105545
[No Abstract] [Full Text] [Related]
13. HTLV-II and a new endemic area for HTLV-I in Brazil.
Moreira Júnior ED; Harrington Júnior W; Ribeiro TT; Melo A; Brites C; Badaró R; Swanson P; Lee H
Rev Soc Bras Med Trop; 1992; 25(2):141-3. PubMed ID: 1308940
[No Abstract] [Full Text] [Related]
14. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
Lee HH; Weiss SH; Brown LS; Mildvan D; Shorty V; Saravolatz L; Chu A; Ginzburg HM; Markowitz N; Des Jarlais DC
J Infect Dis; 1990 Aug; 162(2):347-52. PubMed ID: 2373871
[TBL] [Abstract][Full Text] [Related]
15. Low human T cell leukemia virus type II seroprevalence in Africa.
Bonis J; Verdier M; Dumas M; Denis F
J Infect Dis; 1994 Jan; 169(1):225-7. PubMed ID: 8277189
[No Abstract] [Full Text] [Related]
16. HTLV-I/II seropositivity in populations at high risk for HIV-1 infection in Cordoba City, Argentina.
Medeot S; Nates S; Gallego S; Sileoni S; Maturano E; Recalde Y; Giordano M; Alvarez RB
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):187-8. PubMed ID: 9637585
[No Abstract] [Full Text] [Related]
17. Seroprevalence of HIV and HTLV in a representative sample of the Spanish population.
Castilla J; Pachón I; González MP; Amela C; Muñoz L; Tello O; Noguer I; de Ory F; León P; Alonso M; Gil E; García-Sáiz A
Epidemiol Infect; 2000 Aug; 125(1):159-62. PubMed ID: 11057971
[TBL] [Abstract][Full Text] [Related]
18. HTLV-I/II survey on hemodialysis patients in Buenos Aires.
DeVito C; Pampuro S; Del Pino N; Martinez Peralta L; Libonatti O
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):525-6. PubMed ID: 8757433
[No Abstract] [Full Text] [Related]
19. Regional differences in human retroviral infections HIV-1, HIV-2, and HTLV-I/II in rural Guinea (west Africa).
Jeannel D; Kourouma K; Fretz C; Zheng YM; Ureta VA; Dramé L; Gessain A; Fournel JJ; de Thé G
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):315-8. PubMed ID: 7859147
[No Abstract] [Full Text] [Related]
20. A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populations.
Vranckx R; Coenjaert A; Muylle L
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):827-30. PubMed ID: 2390333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
